查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2028200

去礦化骨市場規模、佔有率、成長及全球產業分析：按類型和應用、區域洞察及2026-2034年預測

Demineralized Bone Matrix Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 125 Pages | 商品交期: 2-3個工作天內

價格

去礦化骨（DBM）市場的成長要素

全球去礦化骨（DBM）市場預計在2025年達到12.5億美元，2026年成長至13.3億美元，2034年達到22.1億美元，預測期內複合年成長率（CAGR）為6.60%。北美市場佔主導地位，預計到2025年將佔44.71%的市場佔有率，這得益於其完善的醫療保健基礎設施和先進整形外科解決方案的廣泛應用。

去礦化骨（DBM）是一種用於骨骼修復和脊椎融合手術的同種異體移植材料。它含有骨形成蛋白（BMP），能夠促進骨再生和癒合，因此在治療骨折、創傷和整形外科疾病方面非常有效。

市場趨勢

整形外科疾病盛行率增加

骨骼肌肉疾病負擔日益加重是推動去礦化骨（DBM）市場發展的主要趨勢。在全球範圍內，數以百萬計的人患有骨質疏鬆症、骨折和骨關節炎等疾病，這使得對骨移植材料的需求十分旺盛。

此外，人口老化和運動傷害的增加也促使整形外科治療需求日益成長。隨著醫療保健意識的提高，諸如去礦化骨（DBM）等先進骨移植替代方案的應用也越來越多。

市場成長要素

脊椎融合手術和牙科手術數量增加

脊椎融合手術數量的不斷增加是推動市場成長要素。椎間盤突出和脊椎損傷等疾病日益常見，也帶動了對去礦化骨（DBM）產品的需求。

此外，人工植牙手術量的增加也推動了市場擴張。去礦化骨（DBM）廣泛應用於牙科手術中，以促進骨再生並提高植入成功率。

增加研發投入

領先企業正大力投資研發，以推出創新去礦化骨（DBM）產品並拓展其應用領域。持續的產品創新有望改善治療效果並加速其在全球的普及。

市場限制因素

DBM產品高成本

儘管去礦化骨產品具有諸多優勢，但其高成本仍是一項重大挑戰，尤其是在新興市場。複雜的生產流程、嚴格的監管要求以及無菌儲存的必要性都顯著推高了成本。

此外，某些手術（特別是牙科骨移植）的保險報銷制度有限，這也是阻礙其廣泛應用的因素。

市場區隔

依產品類型

  • 由於其易用性和在整形外科和牙科手術中的有效性，糊狀材料在市場上佔主導地位。
  • 由於凝膠具有優異的生物相容性，並且在創傷和美容手術中得到越來越廣泛的應用，預計凝膠細分市場將以更高的複合年成長率成長。
  • 其他形式包括用於特殊用途的纖維和片材。

用途別

  • 由於脊椎手術和脊髓損傷病例數量的增加，脊椎融合手術手術部分佔比最大。
  • 由於人工植牙手術的增加，預計牙科領域將迎來顯著成長。
  • 其他應用包括顱顎顏面手術、關節重組和長骨手術。

最終用戶

  • 由於醫院手術量大、手術基礎設施先進，因此醫院正在推動市場發展。
  • 專科診所和其他醫療機構也為市場成長做出了貢獻。

區域趨勢

北美洲

預計北美將引領市場，2025年市場規模將達5.6億美元，2026年將達5.9億美元。這一成長得益於強勁的研發投入和主要行業參與者的存在。

歐洲

預計到 2025 年，歐洲的醫療收入將達到 3.2 億美元，到 2026 年將成長到 3.3 億美元，這得益於先進的醫療保健系統和整形外科手術的增加。

亞太地區

亞太地區是成長最快的地區，預計到 2025 年市場規模將達到 2.8 億美元，到 2026 年將達到 3 億美元。這一成長是由中國、印度和日本不斷增加的醫療保健投資所推動的。

拉丁美洲、中東和非洲

  • 拉丁美洲：5000萬美元（2025年）→ 6000萬美元（2026年）
  • 中東和非洲：5000萬美元（2025年）→ 5000萬美元（2026年）

由於醫療基礎設施的改善，這些地區正在經歷穩定成長。

目錄

第1章：引言

第2章摘要整理

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇

第4章：主要考慮因素

  • 整形外科疾病盛行率：主要國家和地區，2025 年
  • 新冠疫情的影響：全球去鈣骨基質市場
  • 主要行業趨勢
  • 管道分析，主要公司

第5章：全球去礦化骨市場分析、洞察與預測（2021-2034年）

  • 市場分析、洞察與預測：按產品類型分類
    • 凝膠
    • 油灰
    • 其他
  • 市場分析、洞察與預測：按應用領域分類
    • 牙科
    • 顱顎顏面
    • 脊椎固定
    • 長骨手術
    • 關節重組
    • 其他用途
  • 市場分析、洞察與預測：按最終用戶分類
    • 醫院
    • 專科診所
    • 其他
  • 市場分析、洞察與預測：按地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章：北美去礦化骨市場分析、洞察與預測（2021-2034年）

  • 國家
    • 美國
    • 加拿大

第7章：歐洲去礦化骨市場分析、洞察與預測（2021-2034年）

  • 國家
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪地那維亞
    • 其他歐洲國家

第8章：亞太地區去礦化骨市場分析、洞察與預測（2021-2034年）

  • 國家
    • 日本
    • 澳洲
    • 中國
    • 印度
    • 東南亞
    • 其他亞太國家

第9章：拉丁美洲去礦化骨市場分析、洞察與預測（2021-2034年）

  • 國家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章：中東和非洲去礦化骨市場分析、洞察與預測（2021-2034年）

  • 國家
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲國家

第11章 競爭分析

  • 全球市佔率分析（2025 年）
  • 公司簡介
    • Medtronic plc
    • Johnson & Johnson（DePuy Synthes）
    • Zimmer Biomet
    • Stryker
    • Orthofix Holdings, Inc.
    • Xtant Medical
    • RTI Surgical
    • HansBioMed
    • Arthrex GmbH
    • Exactech, Inc.
Product Code: FBI105449

Growth Factors of demineralized bone matrix (DBM) Market

The global demineralized bone matrix (DBM) market was valued at USD 1.25 billion in 2025 and is projected to grow to USD 1.33 billion in 2026, reaching USD 2.21 billion by 2034, registering a CAGR of 6.60% during the forecast period. North America dominated the market with a 44.71% share in 2025, supported by strong healthcare infrastructure and high adoption of advanced orthopedic solutions.

DBM is a type of allograft used in bone repair and spinal fusion procedures. It contains bone morphogenetic proteins (BMPs) that stimulate bone regeneration and healing, making it highly effective in treating fractures, trauma injuries, and orthopedic disorders.

Market Trends

Rising Prevalence of Orthopedic Disorders

The increasing burden of musculoskeletal conditions is a major trend driving the DBM market. Globally, millions suffer from conditions such as osteoporosis, fractures, and osteoarthritis, creating a strong demand for bone grafting materials.

Additionally, the aging population and rising sports-related injuries are contributing to the growing need for orthopedic treatments. As healthcare awareness improves, the adoption of advanced bone graft substitutes like DBM is increasing.

Market Growth Drivers

Increasing Spinal Fusion and Dental Procedures

The rising number of spinal fusion surgeries is a key growth driver for the market. Conditions such as herniated discs and spinal injuries are becoming more common, increasing the demand for DBM products.

Furthermore, the growth in dental implant procedures is boosting market expansion. DBM is widely used in dental surgeries to support bone regeneration and improve implant success rates.

Growing Investments in R&D

Key players are heavily investing in research and development to introduce innovative DBM products and expand their applications. Continuous product innovation is expected to improve treatment outcomes and increase adoption globally.

Market Restraints

High Cost of DBM Products

Despite its benefits, the high cost of DBM products remains a major challenge, especially in emerging economies. The complex manufacturing process, strict regulatory requirements, and need for sterile storage significantly increase costs.

Additionally, limited reimbursement policies for certain procedures, particularly dental bone grafting, restrict widespread adoption.

Market Segmentation

By Product Type

  • Putty Segment dominates the market due to its ease of use and effectiveness in orthopedic and dental procedures.
  • Gel Segment is expected to grow at a higher CAGR due to its superior biocompatibility and increasing use in trauma and aesthetic surgeries.
  • Other forms include fibers and sheets used for specialized applications.

By Application

  • Spinal Fusion Segment holds the largest share due to the rising number of spine surgeries and spinal cord injuries.
  • Dental Segment is expected to grow significantly due to increasing dental implant procedures.
  • Other applications include craniomaxillofacial surgery, joint reconstruction, and long bone procedures.

By End-user

  • Hospitals dominate the market due to higher procedure volumes and availability of advanced surgical infrastructure.
  • Specialty clinics and other healthcare facilities are also contributing to market growth.

Regional Insights

North America

North America led the market with USD 0.56 billion in 2025 and is projected to reach USD 0.59 billion in 2026. Growth is driven by strong R&D investments and the presence of major industry players.

Europe

Europe accounted for USD 0.32 billion in 2025, growing to USD 0.33 billion in 2026, supported by advanced healthcare systems and rising orthopedic procedures.

Asia Pacific

Asia Pacific is the fastest-growing region, with a market size of USD 0.28 billion in 2025, projected to reach USD 0.30 billion in 2026. Growth is driven by increasing healthcare investments in China, India, and Japan.

Latin America & Middle East & Africa

  • Latin America: USD 0.05 billion (2025) -> USD 0.06 billion (2026)
  • Middle East & Africa: USD 0.05 billion (2025) -> USD 0.05 billion (2026)

These regions are witnessing steady growth due to improving healthcare infrastructure.

Key Industry Players

Major companies are focusing on product innovation and strategic collaborations. Key players include:

  • Medtronic
  • Johnson & Johnson
  • Zimmer Biomet
  • Stryker
  • Orthofix

Recent Industry Developments

  • 2023: Orthofix and SeaSpine merged to expand biologics portfolio.
  • 2022: AlloSource launched AlloFuse DBM graft for orthopedic procedures.
  • 2022: Stryker opened a new R&D facility in India.
  • 2019: SeaSpine introduced advanced DBM delivery systems.

Conclusion

The global demineralized bone matrix (DBM) market is set to grow steadily from USD 1.25 billion in 2025 to USD 2.21 billion by 2034, driven by increasing orthopedic disorders, rising spinal fusion and dental procedures, and continuous product innovation. While high costs and reimbursement challenges may limit adoption in some regions, ongoing advancements in bone graft technologies and expanding healthcare infrastructure are expected to support long-term market growth. North America will continue to lead, while Asia Pacific is poised to experience the fastest growth, making the DBM market a key segment in the global orthopedic and regenerative medicine industry.

Segmentation By Product Type

  • Gel
  • Putty
  • Others

By Application

  • Dental
  • Craniomaxillofacial
  • Spinal Fusion
  • Long Bone Procedures
  • Joint Reconstruction
  • Other Applications

By End-user

  • Hospital
  • Specialty Clinics
  • Others

By Region

  • North America (By Product Type, By Application, By End-user, By Country)
    • U.S. (By Product Type)
    • Canada (By Product Type)
  • Europe (By Product Type, By Application, By End-user, By Country/Sub-Region)
    • Germany (By Product Type)
    • U.K. (By Product Type)
    • France (By Product Type)
    • Italy (By Product Type)
    • Spain (By Product Type)
    • Scandinavia (By Product Type)
    • Rest of Europe (By Product Type)
  • Asia Pacific (By Product Type, By Application, By End-user, By Country/Sub-Region)
    • China (By Product Type)
    • India (By Product Type)
    • Japan (By Product Type)
    • Australia (By Product Type)
    • Southeast Asia (By Product Type)
    • Rest of Asia Pacific (By Product Type)
  • Latin America (By Product Type, By Application, By End-user, By Country/Sub-Region)
    • Brazil (By Product Type)
    • Mexico (By Product Type)
    • Rest of Latin America (By Product Type)
  • Middle East & Africa (By Product Type, By Application, By End-user, By Country/Sub-Region)
    • GCC (By Product Type)
    • South Africa (By Product Type)
  • Rest of Middle East & Africa (By Product Type)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities

4. Key Insights

  • 4.1. Prevalence of Orthopaedic Disorders, Key Countries/ Region, 2025
  • 4.2. Impact of COVID-19 on Global Demineralized Bone Matrix (DBM) Market
  • 4.3. Key Industry Developments
  • 4.4. Pipeline Analysis, Key Players

5. Global Demineralized Bone Matrix (DBM) Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product Type
    • 5.1.1. Gel
    • 5.1.2. Putty
    • 5.1.3. Others
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Dental
    • 5.2.2. Craniomaxillofacial
    • 5.2.3. Spinal Fusion
    • 5.2.4. Long Bone Procedures
    • 5.2.5. Joint Reconstruction
    • 5.2.6. Other Applications
  • 5.3. Market Analysis, Insights and Forecast - By End-user
    • 5.3.1. Hospital
    • 5.3.2. Specialty Clinics
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Geography
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Demineralized Bone Matrix (DBM) Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product Type
    • 6.1.1. Gel
    • 6.1.2. Putty
    • 6.1.3. Others
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Dental
    • 6.2.2. Craniomaxillofacial
    • 6.2.3. Spinal Fusion
    • 6.2.4. Long Bone Procedures
    • 6.2.5. Joint Reconstruction
    • 6.2.6. Other Applications
  • 6.3. Market Analysis, Insights and Forecast - By End-user
    • 6.3.1. Hospital
    • 6.3.2. Specialty Clinics
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
      • 6.4.1.1. Product Type
    • 6.4.2. Canada
      • 6.4.2.1. Product Type

7. Europe Demineralized Bone Matrix (DBM) Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product Type
    • 7.1.1. Gel
    • 7.1.2. Putty
    • 7.1.3. Others
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Dental
    • 7.2.2. Craniomaxillofacial
    • 7.2.3. Spinal Fusion
    • 7.2.4. Long Bone Procedures
    • 7.2.5. Joint Reconstruction
    • 7.2.6. Other Applications
  • 7.3. Market Analysis, Insights and Forecast - By End-user
    • 7.3.1. Hospital
    • 7.3.2. Specialty Clinics
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.4.1. U.K.
      • 7.4.1.1. Product Type
    • 7.4.2. Germany
      • 7.4.2.1. Product Type
    • 7.4.3. France
      • 7.4.3.1. Product Type
    • 7.4.4. Spain
      • 7.4.4.1. Product Type
    • 7.4.5. Italy
      • 7.4.5.1. Product Type
    • 7.4.6. Scandinavia
      • 7.4.6.1. Product Type
    • 7.4.7. Rest of Europe
      • 7.4.7.1. Product Type

8. Asia Pacific Demineralized Bone Matrix (DBM) Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product Type
    • 8.1.1. Gel
    • 8.1.2. Putty
    • 8.1.3. Others
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Dental
    • 8.2.2. Craniomaxillofacial
    • 8.2.3. Spinal Fusion
    • 8.2.4. Long Bone Procedures
    • 8.2.5. Joint Reconstruction
    • 8.2.6. Other Applications
  • 8.3. Market Analysis, Insights and Forecast - By End-user
    • 8.3.1. Hospital
    • 8.3.2. Specialty Clinics
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 8.4.1. Japan
      • 8.4.1.1. Product Type
    • 8.4.2. Australia
      • 8.4.2.1. Product Type
    • 8.4.3. China
      • 8.4.3.1. Product Type
    • 8.4.4. India
      • 8.4.4.1. Product Type
    • 8.4.5. Southeast Asia
      • 8.4.5.1. Product Type
    • 8.4.6. Rest of APAC
      • 8.4.6.1. Product Type

9. Latin America Demineralized Bone Matrix (DBM) Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product Type
    • 9.1.1. Gel
    • 9.1.2. Putty
    • 9.1.3. Others
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Dental
    • 9.2.2. Craniomaxillofacial
    • 9.2.3. Spinal Fusion
    • 9.2.4. Long Bone Procedures
    • 9.2.5. Joint Reconstruction
    • 9.2.6. Other Applications
  • 9.3. Market Analysis, Insights and Forecast - By End-user
    • 9.3.1. Hospital
    • 9.3.2. Specialty Clinics
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country
    • 9.4.1. Brazil
      • 9.4.1.1. Product Type
    • 9.4.2. Mexico
      • 9.4.2.1. Product Type
    • 9.4.3. Rest of Latin America
      • 9.4.3.1. Product Type

10. Middle East & Africa Demineralized Bone Matrix (DBM) Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product Type
    • 10.1.1. Gel
    • 10.1.2. Putty
    • 10.1.3. Others
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Dental
    • 10.2.2. Craniomaxillofacial
    • 10.2.3. Spinal Fusion
    • 10.2.4. Long Bone Procedures
    • 10.2.5. Joint Reconstruction
    • 10.2.6. Other Applications
  • 10.3. Market Analysis, Insights and Forecast - By End-user
    • 10.3.1. Hospital
    • 10.3.2. Specialty Clinics
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country
    • 10.4.1. GCC Countries
      • 10.4.1.1. Product Type
    • 10.4.2. South Africa
      • 10.4.2.1. Product Type
    • 10.4.3. Rest of Middle East & Africa
      • 10.4.3.1. By Product Type

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Medtronic plc
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & Services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Johnson & Johnson (DePuy Synthes)
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & Services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Zimmer Biomet
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & Services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Stryker
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & Services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Orthofix Holdings, Inc.
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & Services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Xtant Medical
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & Services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. RTI Surgical
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & Services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. HansBioMed
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & Services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. Arthrex GmbH
      • 11.2.9.1. Overview
      • 11.2.9.2. Products & Services
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. Exactech, Inc.
      • 11.2.10.1. Overview
      • 11.2.10.2. Products & Services
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 2: Global Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 3: Global Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 4: Global Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 5: North America Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 6: North America Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 7: North America Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 8: North America Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 9: U.S. Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 10: Canada Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 11: Europe Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 12: Europe Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 13: Europe Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 14: Europe Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 15: Germany Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 16: France Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 17: U.K. Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 18: Italy Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 19: Spain Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 20: Scandinavia Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 21: Rest of Europe Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 22: Asia Pacific Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 23: Asia Pacific Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 24: Asia Pacific Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 25: Asia Pacific Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 26: China Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 27: Japan Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 28: India Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 29: Australia Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 30: Southeast Asia Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 31: Rest of Asia Pacific Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 32: Latin America Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 33: Latin America Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 34: Latin America Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 35: Latin America Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 36: Brazil Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 37: Mexico Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 38: Rest of Latin America Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 39: Middle East & Africa Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 40: Middle East & Africa Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 41: Middle East & Africa Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 42: Middle East & Africa Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 43: GCC Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 44: South Africa Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 45: Rest of Middle East & Africa Demineralized Bone Matrix (DBM) Market Revenue (USD billion) Forecast, By Product Type, 2021-2034

List of Figures

  • Figure 1: Global Demineralized Bone Matrix (DBM) Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Demineralized Bone Matrix (DBM) Market Value Share (%), by Product Type, 2025 & 2034
  • Figure 3: Global Demineralized Bone Matrix (DBM) Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Demineralized Bone Matrix (DBM) Market Value Share (%), by End-user, 2025 & 2034
  • Figure 5: Global Demineralized Bone Matrix (DBM) Market Value (USD billion), by Region, 2025 & 2034
  • Figure 6: North America Demineralized Bone Matrix (DBM) Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 7: North America Demineralized Bone Matrix (DBM) Market Value Share (%), by Product Type, 2025
  • Figure 8: North America Demineralized Bone Matrix (DBM) Market Value (USD billion), by Application, 2025 & 2034
  • Figure 9: North America Demineralized Bone Matrix (DBM) Market Value Share (%), by Application, 2025
  • Figure 10: North America Demineralized Bone Matrix (DBM) Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 11: North America Demineralized Bone Matrix (DBM) Market Value Share (%), by End-user, 2025
  • Figure 12: North America Demineralized Bone Matrix (DBM) Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Demineralized Bone Matrix (DBM) Market Value Share (%), By Country, 2025
  • Figure 14: Europe Demineralized Bone Matrix (DBM) Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 15: Europe Demineralized Bone Matrix (DBM) Market Value Share (%), by Product Type, 2025
  • Figure 16: Europe Demineralized Bone Matrix (DBM) Market Value (USD billion), by Application, 2025 & 2034
  • Figure 17: Europe Demineralized Bone Matrix (DBM) Market Value Share (%), by Application, 2025
  • Figure 18: Europe Demineralized Bone Matrix (DBM) Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 19: Europe Demineralized Bone Matrix (DBM) Market Value Share (%), by End-user, 2025
  • Figure 20: Europe Demineralized Bone Matrix (DBM) Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Demineralized Bone Matrix (DBM) Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Demineralized Bone Matrix (DBM) Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 23: Asia Pacific Demineralized Bone Matrix (DBM) Market Value Share (%), by Product Type, 2025
  • Figure 24: Asia Pacific Demineralized Bone Matrix (DBM) Market Value (USD billion), by Application, 2025 & 2034
  • Figure 25: Asia Pacific Demineralized Bone Matrix (DBM) Market Value Share (%), by Application, 2025
  • Figure 26: Asia Pacific Demineralized Bone Matrix (DBM) Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 27: Asia Pacific Demineralized Bone Matrix (DBM) Market Value Share (%), by End-user, 2025
  • Figure 28: Asia Pacific Demineralized Bone Matrix (DBM) Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Demineralized Bone Matrix (DBM) Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Latin America Demineralized Bone Matrix (DBM) Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 31: Latin America Demineralized Bone Matrix (DBM) Market Value Share (%), by Product Type, 2025
  • Figure 32: Latin America Demineralized Bone Matrix (DBM) Market Value (USD billion), by Application, 2025 & 2034
  • Figure 33: Latin America Demineralized Bone Matrix (DBM) Market Value Share (%), by Application, 2025
  • Figure 34: Latin America Demineralized Bone Matrix (DBM) Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 35: Latin America Demineralized Bone Matrix (DBM) Market Value Share (%), by End-user, 2025
  • Figure 37: Latin America Demineralized Bone Matrix (DBM) Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 38: Latin America Demineralized Bone Matrix (DBM) Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 39: Middle East & Africa Demineralized Bone Matrix (DBM) Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 40: Middle East & Africa Demineralized Bone Matrix (DBM) Market Value Share (%), by Product Type, 2025
  • Figure 41: Middle East & Africa Demineralized Bone Matrix (DBM) Market Value (USD billion), by Application, 2025 & 2034
  • Figure 42: Middle East & Africa Demineralized Bone Matrix (DBM) Market Value Share (%), by Application, 2025
  • Figure 43: Middle East & Africa Demineralized Bone Matrix (DBM) Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 44: Middle East & Africa Demineralized Bone Matrix (DBM) Market Value Share (%), by End-user, 2025
  • Figure 45: Middle East & Africa Demineralized Bone Matrix (DBM) Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 46: Middle East & Africa Demineralized Bone Matrix (DBM) Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 47: Global Demineralized Bone Matrix (DBM) Market Share (%), By Company, 2025